Objectives To describe the frequency and determinants of self-medication for symptoms of sexually transmitted infections (STI) in a female sex worker (FSW) population. To present a methodology exploring the best predictors as well as the interactions between determinants of self-medication.
Methods A cross-sectional survey of 4153 FSW carried out in Peru. The prevalence of self-medication was estimated from the subsample of participants who had experienced symptoms of STI in the past 12 months (n=1601), and used successive logistic regression models to explore the determinants.
Results Self-medication prevalence for a reported symptomatic episode during the past 12 months was 32.1% (95% CI 29.8 to 34.6). It was negatively correlated with work in brothels (adjusted odds ratio (OR) 0.51, 95% CI 0.28 to 0.93; p=0.028) and awareness of STI services available for FSW (adjusted OR 0.49, 95% CI 0.29 to 0.81; p=0.006). Other determinants were organised at different levels of proximity to the outcome creating pathways leading to self-medication.
Conclusions The importance of the staggered analysis presented in this study resides in its potential to improve the understanding of associations between determinants and, consequently, the targeting of interventions. The awareness of STI services available for FSW increases access to health care, which in turn decreases self-medication. In addition, the sharing of information that takes place between brothel-based FSW was also related to a diminishing prevalence of self-medication. These two main predictors provide an opportunity for prevention programmes, in particular those designed to be led by peers.
- female sex worker
- sexually transmitted infections
- social epidemiology
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding The PREVEN study is funded by the Wellcome Trust Foundation, (#GR-078835), National Institutes of Health CIPRA (#AI-053218) and NIH/NIAID UW STI/Topical Microbicide Cooperative Research Center (#AI-031448). GBG was funded by the Medical Research Council, UK.
Competing interests HW is co-editor of the journal Sexually Transmitted Infections. All other authors declare no conflicts of interest.
Patient consent Obtained.
Ethics approval The PREVEN study obtained ethics approval from institutional review boards at the Universidad Peruana Cayetano Heredia, the University of Washington in Seattle and the US Navy Medical Research Center Detachment in Lima, which has been renewed every year.
Provenance and peer review Not commissioned; externally peer reviewed.